Xenon Pharmaceuticals

XENE

Börsenwert 4,01 Mrd. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 BVF Inc San Francisco, California	25,2 Mio. $	+10,3 Mio. $	+1.333.333	+75 %
2	2 Capital World Investors Los Angeles, California	8,34 Mio. $	–	–	–
3	3 OrbiMed New York	8,1 Mio. $	+7,72 Mio. $	+1.000.000	Neu
4	4 Perceptive Advisors New York	6,18 Mio. $	+2,55 Mio. $	+330.000	+76 %
5	5 Tekla Capital Management Boston, Massachusetts	5,67 Mio. $	+5,41 Mio. $	+700.000	Neu
6	6 DAFNA Capital Management Los Angeles, California	4,16 Mio. $	+2,32 Mio. $	+300.000	+140 %
7	7 Invesco Private Capital New York	3,34 Mio. $	-184.654 $	-23.905	-5 %
8	OM 8 Opaleye Management Boston, Massachusetts	3,32 Mio. $	–	–	–
9	9 Royal Bank of Canada Toronto, Ontario, Canada	2,98 Mio. $	-194.449 $	-25.173	-6 %
10	10 Point72 Asset Management Stamford, Connecticut	2,9 Mio. $	–	–	–
11	GTC 11 Ghost Tree Capital New York	2,63 Mio. $	+2,51 Mio. $	+325.000	Neu
12	12 Highland Capital Management (Texas) Dallas, Texas	2,02 Mio. $	+1,93 Mio. $	+250.000	Neu
13	13 Sphera Funds Management Tel Aviv, Israel	1,85 Mio. $	+1,76 Mio. $	+228.029	Neu
14	14 Novo Holdings A/S Hellerup, Denmark	1,03 Mio. $	–	–	–
15	15 Renaissance Technologies New York	779.000 $	+368.459 $	+47.700	+98 %
16	16 State of New Jersey Common Pension Fund D Trenton, New Jersey	527.000 $	–	–	–
17	17 Weiss Multi-Strategy Advisers New York	255.000 $	-6.952 $	-900	-3 %
18	18 Deutsche Bank Frankfurt Am Main Ge, Germany	232.000 $	+193.900 $	+25.102	+688 %
19	19 Monashee Investment Management Boston, Massachusetts	203.000 $	–	–	–
20	20 Leith Wheeler Investment Counsel Vancouver, British Columbia, Canada	171.000 $	-13.858 $	-1.794	-10 %
21	21 Scotia Capital Toronto, Ontario, Canada	169.000 $	+160.824 $	+20.820	Neu
22	22 NJ State Employees Deferred Compensation Plan Trenton, New Jersey	162.000 $	–	–	–
23	KPF 23 K2 Principal Fund Toronto, Ontario, Canada	122.000 $	+115.868 $	+15.000	Neu
24	24 M&T Bank Buffalo, New York	115.000 $	+110.082 $	+14.251	Neu
25	25 Bank of Montreal Toronto, Ontario, Canada	58.000 $	–	–	–

Xenon Pharmaceuticals XENE Börsenwert 4,01 Mrd. $

Xenon Pharmaceuticals

XENE

Börsenwert 4,01 Mrd. $